At a glance
- Originator Pierre Fabre
- Class Anxiolytics; Neuroprotectants
- Mechanism of Action GABA A receptor agonists; GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 13 Feb 1995 Discontinued-I for Anxiety disorders in France (Unknown route)